Christopher Robert Cunningham

Christopher Cunningham practices at PAM Health Rehabilitation Hospital of Tulsa in Tulsa, Oklahoma, part of Post Acute Medical.

Christopher Cunningham's NPI, 1194083048, was assigned on April 30, 2012. Christopher Cunningham graduated from University of Oklahoma College of Medicine in 2012. Christopher Cunningham holds Alabama license 33097.

Christopher Cunningham's primary practice is PAM Health Rehabilitation Hospital of Tulsa, at 10020 East 91st Street, Tulsa, OK 74133 in Tulsa County. The practice phone is (918) 940-8801.

Christopher Cunningham's primary practice is PAM Health Rehabilitation Hospital of Tulsa in Tulsa, Oklahoma, part of Post Acute Medical. Christopher Cunningham is also affiliated with Saint Francis Hospital. Dmand AI also links Christopher Cunningham to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Cunningham practices, 6 sites in all. Vendor and product names are available with a free account.

Physical medicine and rehabilitation is Christopher Cunningham's primary specialty in the NPI Registry, under taxonomy code 208100000X. Christopher Cunningham is licensed in Alabama.

CMS data shows 2,600 Medicare services from Christopher Cunningham across 5 procedure codes in 2024, for 313 Medicare patients. Medicare paid $170,070 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 313 Medicare patients who saw Christopher Cunningham in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Cunningham's median patient age at 71, with 58% women.

In 2024, Christopher Cunningham wrote 992 Medicare Part D claims for 259 patients. 91% of them were for generic drugs. CMS names the drug for 642 of them, across 26 drugs with 11 or more claims each, at $28,259 in total drug cost. In 2023, CMS named 760 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Christopher Cunningham for performance year 2024, reported individually. Christopher Cunningham accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Christopher Cunningham from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $59.

Christopher Cunningham graduated from University of Oklahoma College of Medicine in 2012.